Design and baseline characteristics of theAMPLITUDE-Ocardiovascular outcomes trial of efpeglenatide, a weekly glucagon-like peptide-1 receptor agonist Article

Industry Collaboration International Collaboration

cited authors

  • Gerstein, Hertzel C.; Branch, Kelley; Heenan, Laura; Del Prato, Stefano; Khurmi, Nardev S.; Lam, Carolyn S. P.; Pratley, Richard; Rosenstock, Julio; Sattar, Naveed

authors

Publication Date

  • October 22, 2020

webpage

published in

category

keywords

  • GLP-1 analogue
  • antidiabetic drug
  • cardiovascular disease
  • clinical trial
  • macrovascular disease

start page

  • 318

end page

  • 323

volume

  • 23

issue

  • 2